Armata Pharmaceuticals (ARMP) Change in Receivables (2013 - 2017)
Armata Pharmaceuticals (ARMP) posted Change in Receivables of -$2000.0 for Q2 2017, up 80.0% sequentially from -$10000.0 in Q1 2017, and down 150.0% YoY from $4000.0 in Q2 2016.
Armata Pharmaceuticals (ARMP) Change in Receivables (2013 - 2017) Analysis & Trends
Armata Pharmaceuticals has reported Change in Receivables for 5 years, with the latest figure at -$2000.0 in Q2 2017.
- Quarterly Change in Receivables fell 150.0% year-over-year to -$2000.0 in Q2 2017, while the trailing twelve-month figure through Sep 2017 was -$11000.0 (up 31.25% YoY) and the FY2020 annual result came in at $467000.0, changed N/A from the prior year.
- Change in Receivables grew to -$2000.0 in Q2 2017 per ARMP's latest filing, from -$10000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $129000.0 in Q2 2013 and troughed at -$140000.0 in Q4 2013.
- A 5-year average of -$588.24 and a median of $4000.0 in 2014 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2014 and 2015: Change in Receivables soared 152.14% in 2014, then sank 2600.0% in 2015.
- Over 5 years, Change in Receivables stood at -$140000.0 in 2013, then jumped by 152.14% to $73000.0 in 2014, then rose by 16.44% to $85000.0 in 2015, then tumbled by 98.82% to $1000.0 in 2016, then slumped by 300.0% to -$2000.0 in 2017.
- According to Business Quant data, Change in Receivables over the past three periods registered -$2000.0, -$10000.0, and $1000.0 for Q2 2017, Q1 2017, and Q4 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -2,000.00 |
| Mar 31, 2017 | -10,000.00 |
| Mar 31, 2017 | -10,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Mar 31, 2016 | -111,000.00 |
| Mar 31, 2016 | -111,000.00 |
| Dec 31, 2015 | 85,000.00 |
| Dec 31, 2015 | 85,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Mar 31, 2015 | -100,000.00 |
| Mar 31, 2015 | -100,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Dec 31, 2014 | 73,000.00 |